Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304889 · ClinicalTrials.gov registry record
Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
A clinical trial, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- 52
- Enrollment target
NCT00304889: Completed study, sponsored by Michael E. DeBakey VA Medical Center.
NCT00304889 is a clinical trial that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00304889 has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the outcome of treatment with nitazoxanide vs. vancomycin for diarrheal disease due to Clostridium difficile in patients who have failed previous treatment with metronidazole.
Primary Outcome
Number of day to resolution to three formed or loose stools per day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-01 |
What the finished NCT00304889 record still lists
NCT00304889 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00304889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00304889 about?
NCT00304889 is a clinical study titled "Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis". The purpose of this study is to compare the outcome of treatment with nitazoxanide vs. vancomycin for diarrheal disease due to Clostridium difficile in patients who have failed previous treatment with metronidazole.
What is the current status of trial NCT00304889?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2006-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00304889?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia